Applikations-hinweise | Optimal working dilution should be determined by the investigator. |
Beschränkungen | Nur für Forschungszwecke einsetzbar |
Format | Liquid |
Konzentration | 0.25 mg/mL |
Buffer | PBS with 0.09 % (W/V) sodium azide |
Konservierungs-mittel | Sodium azide |
Vorsichtsmaßnahmen | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Handhabung | Avoid repeated freezing and thawing. |
Lagerung | 4 °C/-20 °C |
Informationen zur Lagerung | Store at 2 - 8 °C for up to six months or (in aliquots) at -20 °C for longer. |
Bilder des Herstellers |
Produkt verwendet in: |
Ross, Katzov-Eckert, Dubé, Brooks, Rassekh, Barhdadi, Feroz-Zada, Visscher, Brown, Rieder, Rogers, Phillips, Carleton, Hayden: "Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy." in: Nature genetics, Vol. 41, Issue 12, pp. 1345-9, 2009 (PubMed).
|